PT1650219E - Homólogos de toll humana - Google Patents
Homólogos de toll humana Download PDFInfo
- Publication number
- PT1650219E PT1650219E PT05023238T PT05023238T PT1650219E PT 1650219 E PT1650219 E PT 1650219E PT 05023238 T PT05023238 T PT 05023238T PT 05023238 T PT05023238 T PT 05023238T PT 1650219 E PT1650219 E PT 1650219E
- Authority
- PT
- Portugal
- Prior art keywords
- human toll
- pro286
- pro285
- pro358
- proteins
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6225097P | 1997-10-17 | 1997-10-17 | |
US6531197P | 1997-11-13 | 1997-11-13 | |
US8332298P | 1998-04-28 | 1998-04-28 | |
US10541398A | 1998-06-26 | 1998-06-26 | |
US9086398P | 1998-06-26 | 1998-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1650219E true PT1650219E (pt) | 2008-03-31 |
Family
ID=27535565
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT07020354T PT1887014E (pt) | 1997-10-17 | 1998-10-07 | Homëlogos de toll humana |
PT05023238T PT1650219E (pt) | 1997-10-17 | 1998-10-07 | Homólogos de toll humana |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT07020354T PT1887014E (pt) | 1997-10-17 | 1998-10-07 | Homëlogos de toll humana |
Country Status (11)
Country | Link |
---|---|
EP (3) | EP1650219B1 (pt) |
JP (3) | JP4319348B2 (pt) |
AT (3) | ATE381574T1 (pt) |
AU (1) | AU1070399A (pt) |
CA (1) | CA2305385C (pt) |
DE (3) | DE69838888T2 (pt) |
DK (3) | DK1887014T3 (pt) |
ES (2) | ES2298905T3 (pt) |
IL (4) | IL135345A0 (pt) |
PT (2) | PT1887014E (pt) |
WO (1) | WO1999020756A2 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696327B1 (en) | 1997-10-17 | 2010-04-13 | Genentech, Inc. | Antibodies to human Toll homologues |
AU2001264889B2 (en) * | 1997-05-07 | 2006-06-29 | Schering Corporation | Human receptor proteins; related reagents and methods |
US20030032090A1 (en) | 1997-05-07 | 2003-02-13 | Schering Corporation, A New Jersey Corporation | Human receptor proteins; related reagents and methods |
CN101486759A (zh) * | 1997-05-07 | 2009-07-22 | 先灵公司 | 人Toll样受体蛋白、相关试剂和方法 |
US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
MXPA02011618A (es) * | 2000-05-25 | 2003-03-10 | Schering Corp | Proteinas de receptor de humano, reactivos y metodos relacionados. |
WO2002022809A2 (en) | 2000-09-15 | 2002-03-21 | Coley Pharmaceutical Gmbh | PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
US7220723B2 (en) | 2001-05-15 | 2007-05-22 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
EP1293566A1 (en) * | 2001-09-17 | 2003-03-19 | Societe Des Produits Nestle S.A. | A soluble toll-like receptor |
US20060058288A1 (en) * | 2002-04-08 | 2006-03-16 | Masayuki Ii | Severe sepsis preventive therapeutic agent |
WO2004108069A2 (en) | 2002-05-04 | 2004-12-16 | Acorda Therapeutics, Inc. | Compositions and methods for promoting neuronal outgrowth |
MXPA05005071A (es) | 2002-11-12 | 2005-07-22 | Becton Dickinson Co | Diagnostico de la sepsis o sirs usando perfiles de biomarcadores. |
WO2004047612A2 (en) * | 2002-11-22 | 2004-06-10 | Nuvelo, Inc. | Methods of therapy and diagnosis |
WO2004094671A2 (en) * | 2003-04-22 | 2004-11-04 | Coley Pharmaceutical Gmbh | Methods and products for identification and assessment of tlr ligands |
US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
EP2460881B1 (en) * | 2003-05-16 | 2017-05-03 | Acorda Therapeutics, Inc. | Proteoglycan degrading mutants for treatment of CNS |
US7696169B2 (en) | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
US8163506B2 (en) | 2003-06-17 | 2012-04-24 | Meiji Co., Ltd. | Use of toll-like receptor-expressing cells |
JP4562123B2 (ja) * | 2003-06-17 | 2010-10-13 | 明治乳業株式会社 | Toll様レセプター強制発現細胞の利用 |
CN1878793A (zh) | 2003-09-11 | 2006-12-13 | 鉴定医疗有限公司 | 拮抗hmgb1的单克隆抗体 |
WO2005112986A2 (en) | 2004-05-18 | 2005-12-01 | Acorda Therapeutics, Inc. | Purifying chondroitinase and stable formulations thereof |
WO2006083275A2 (en) * | 2004-05-21 | 2006-08-10 | The Uab Research Foundation | Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof |
JP2008538007A (ja) | 2005-04-15 | 2008-10-02 | ベクトン,ディッキンソン アンド カンパニー | 敗血症の診断 |
JP5189985B2 (ja) | 2005-09-26 | 2013-04-24 | アコーダ セラピューティクス、インク. | コンドロイチナーゼabci変異体を用いた組成物およびその使用方法 |
ES2435775T3 (es) | 2005-10-27 | 2013-12-23 | Janssen Biotech, Inc. | Moduladores de receptor tipo Toll 3, procedimientos y usos |
AU2007297565A1 (en) * | 2006-04-19 | 2008-03-27 | Genentech, Inc. | Novel gene disruptions, compositions and methods relating thereto |
ES2473610T3 (es) | 2006-10-10 | 2014-07-07 | Acorda Therapeutics, Inc. | Composiciones y métodos de uso de mutantes de condroitinasa ABCI |
WO2009123737A2 (en) | 2008-04-03 | 2009-10-08 | Becton, Dickinson And Company | Advanced detection of sepsis |
MY163936A (en) | 2010-01-27 | 2017-11-15 | Takeda Pharmaceuticals Co | Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
CA1338518C (en) | 1987-09-23 | 1996-08-13 | Joyce M. Zarling | Antibody heteroconjugates for the killing of hiv-infected cells |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
WO1991000360A1 (en) | 1989-06-29 | 1991-01-10 | Medarex, Inc. | Bispecific reagents for aids therapy |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
JPH06507398A (ja) | 1991-05-14 | 1994-08-25 | リプリジェン コーポレーション | Hiv感染治療のための異種複合抗体 |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
CN101486759A (zh) * | 1997-05-07 | 2009-07-22 | 先灵公司 | 人Toll样受体蛋白、相关试剂和方法 |
ATE325815T1 (de) * | 1998-03-25 | 2006-06-15 | Genentech Inc | Menschliches neurotrimin-homolog |
-
1998
- 1998-10-07 DK DK07020354.2T patent/DK1887014T3/da active
- 1998-10-07 EP EP05023238A patent/EP1650219B1/en not_active Expired - Lifetime
- 1998-10-07 PT PT07020354T patent/PT1887014E/pt unknown
- 1998-10-07 ES ES05023238T patent/ES2298905T3/es not_active Expired - Lifetime
- 1998-10-07 AT AT05023238T patent/ATE381574T1/de active
- 1998-10-07 JP JP2000517077A patent/JP4319348B2/ja not_active Expired - Lifetime
- 1998-10-07 EP EP07020354A patent/EP1887014B1/en not_active Expired - Lifetime
- 1998-10-07 DK DK98953294T patent/DK1025227T3/da active
- 1998-10-07 AT AT98953294T patent/ATE314471T1/de not_active IP Right Cessation
- 1998-10-07 AU AU10703/99A patent/AU1070399A/en not_active Abandoned
- 1998-10-07 DE DE69838888T patent/DE69838888T2/de not_active Expired - Lifetime
- 1998-10-07 EP EP98953294A patent/EP1025227B1/en not_active Revoked
- 1998-10-07 IL IL13534598A patent/IL135345A0/xx active IP Right Grant
- 1998-10-07 CA CA2305385A patent/CA2305385C/en not_active Expired - Lifetime
- 1998-10-07 AT AT07020354T patent/ATE463502T1/de active
- 1998-10-07 PT PT05023238T patent/PT1650219E/pt unknown
- 1998-10-07 ES ES07020354T patent/ES2343210T3/es not_active Expired - Lifetime
- 1998-10-07 DE DE69841607T patent/DE69841607D1/de not_active Expired - Lifetime
- 1998-10-07 DE DE69833014T patent/DE69833014T2/de not_active Revoked
- 1998-10-07 WO PCT/US1998/021141 patent/WO1999020756A2/en active Application Filing
- 1998-10-07 DK DK05023238T patent/DK1650219T3/da active
-
2000
- 2000-03-29 IL IL135345A patent/IL135345A/en not_active IP Right Cessation
-
2007
- 2007-01-25 IL IL180967A patent/IL180967A/en not_active IP Right Cessation
-
2008
- 2008-12-24 JP JP2008328570A patent/JP5027105B2/ja not_active Expired - Lifetime
-
2012
- 2012-01-31 JP JP2012017737A patent/JP5425244B2/ja not_active Expired - Lifetime
- 2012-08-09 IL IL221367A patent/IL221367A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL180967A0 (en) | Human toll homologues | |
HK1027577A1 (en) | Selection of proteins using rna-protein fusions | |
ATE329028T1 (de) | Nl3 tie rezeptortyrosinekinase ligandhomologe | |
EP0832973A3 (en) | GTP-binding protein | |
ATE394484T1 (de) | Smad 6 und dessen anwendungen | |
EP1517144A3 (en) | Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor | |
EP1246686A4 (en) | RAPID IDENTIFICATION OF PROTEINS USING ANTIBODY MIXTURES | |
MXPA01008605A (es) | Proteina de enlace del antigeno goodpasture. | |
GB9816514D0 (en) | Novel method | |
GB2332906A8 (en) | Nucleic acids encoding TTX-resistant Na channel proteins | |
EP0816498A3 (en) | Excitatory amino acid receptor protein and related nucleic acid compounds | |
ES2178203T3 (es) | Metodos y reactivos para modular la apoptosis. | |
DE59712604D1 (de) | Mittel zur identifizierung und therapie metastasierender tumore | |
WO2000034294A3 (en) | Tumor necrosis factor receptor homologue-1 ('trh1') | |
WO1998002557A3 (en) | MAMMALIAN TNF-α CONVERTASES | |
EP0893501A3 (en) | Ferrichrome transport atp-binding protein | |
WO2001021794A3 (en) | Smad associating polypeptides | |
MX9701904A (es) | Proteinas de enlace de pka novedosas y usos de las mismas. |